Cowden's disease:: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation

被引:31
作者
Reifenberger, J
Rauch, L
Beckmann, MW
Megahed, M
Ruzicka, T
Reifenberger, G
机构
[1] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany
[3] Univ Erlangen Nurnberg, Dept Gynaecol, Erlangen, Germany
关键词
breast carcinoma; Cowden's disease; mutation; PTEN; TP53;
D O I
10.1046/j.1365-2133.2003.05322.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report a 54-year-old woman with Cowden's disease (CD) who was found to carry a novel germline mutation in the PTEN gene. The mutation (c.334C-->G) introduced a splice donor site within exon 5 that caused the expression of an aberrant transcript lacking 159 nucleotides corresponding to codons 112-164. Clinically, the patient showed multiple benign hamartomatous lesions of the skin, papillomatosis of the lips and oral mucosa, polyposis coli and bilateral fibrocystic disease of the breast. In addition, she developed different types of malignant neoplasms, including bilateral carcinomas of the breast and malignant melanomas of the skin. Molecular genetic analysis of a benign skin hamartoma and an invasive ductal breast carcinoma revealed loss of heterozygosity (LOH) at microsatellite markers on chromosome 10 in the carcinoma but not in the hamartoma. The breast carcinoma additionally carried a somatic TP53 point mutation (c.466C-->G; R156G) that was associated with LOH on 17p and nuclear p53 protein accumulation. Taken together, our findings indicate that benign hamartomas in CD may develop without loss of the second (wild-type) PTEN allele, whereas the pathogenesis of malignant tumours, such as breast carcinomas, appears to require the complete inactivation of Pten as well as further alterations such as the loss of p53-dependent growth control.
引用
收藏
页码:1040 / 1046
页数:7
相关论文
共 35 条
[1]   Multistep carcinogenesis of breast cancer and tumour heterogeneity [J].
Beckmann, MW ;
Niederacher, D ;
Schnurch, HG ;
Gusterson, BA ;
Bender, HG .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (06) :429-439
[2]  
Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO
[3]  
2-0
[4]   Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas [J].
Bostrom, J ;
Muhlbauer, A ;
Reifenberger, G .
ACTA NEUROPATHOLOGICA, 1997, 94 (05) :479-485
[5]   PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome [J].
Bussaglia, E ;
Pujol, RM ;
Gil, MJ ;
Martí, RM ;
Tuneu, A ;
Febrer, MI ;
Garcia-Patos, V ;
Ruiz, EM ;
Barnadas, M ;
Alegre, M ;
Serrano, S ;
Matias-Guiu, X .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (04) :639-644
[6]  
Çelebi JT, 2000, HUM GENET, V107, P234
[7]   Germline PTEN mutations in three families with Cowden syndrome [J].
Çelebi, JT ;
Ping, XL ;
Zhang, H ;
Remington, T ;
Sulica, VI ;
Tsou, HC ;
Peacocke, M .
EXPERIMENTAL DERMATOLOGY, 2000, 9 (02) :152-156
[8]   Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers [J].
De Vivo, I ;
Gertig, DM ;
Nagase, S ;
Hankinson, SE ;
O'Brien, R ;
Speizer, FE ;
Parsons, R ;
Hunter, DJ .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (05) :336-341
[9]   Pten is essential for embryonic development and tumour suppression [J].
Di Cristofano, A ;
Pesce, B ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE GENETICS, 1998, 19 (04) :348-355
[10]   Will the real Cowden syndrome please stand up: revised diagnostic criteria [J].
Eng, C .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (11) :828-830